Tag Archives: patent

Patents Improve Public Health: Progressive Economy Reviews TRIPS at 20 Years

flags with blue sky

Progressive Economy released a research paper examining the effect of TRIPS (Trade-Related Aspects of Intellectual Property) on global health. Here are their findings quoted from their press release: “1. Since the TRIPS agreement went into effect on New Year’s Day 1995, research and development spending has risen significantly worldwide (relative to the size of GDP). For OECD members, the rise is from 2.1 percent to 2.4 percent of GDP, or in practice an additional $220 Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Neglected Diseases: What if IP was the Cure?

Biopharmaceuticals and Accountable Care Organizations: Balancing Cost and Quality

The Lancet Global Health Journal recently published an article “The drug and vaccine landscape for neglected diseases (2000-11): a systematic assessment” discussing the current research and development ongoing in this area.  They found 1,500 clinical trials were registered for neglected diseases which represents only 1% of all registered clinical trial activity.  Of the 123 new products in development for neglected disease, more than half were vaccines or biological products.  However, the article points out that Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , ,

South Africa National Policy on Intellectual Property: Inconsistent with Biotech Development Goals

South-African-Flag

BIO submitted comments this week to the government of South Africa on their proposed “Draft National Policy on Intellectual Property.”  Below are some highlights. “BIO and its member companies are aware of the South African government’s aspirations to develop its life sciences industry, a message that South African officials communicated clearly at the recent BIO International Conference in Chicago, USA, in April 2013. At that conference and in subsequent discussions, South African officials have sent Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

The “Designer Baby” Patent: Why the Patent System Should Not Regulate Science

family_115x76

23andMe received criticism this week from a few bioethicists in the journal Genetics in Medicine, regarding a patent titled “gamete donor selection based on genetic calculations.”   The ethicists write,  “Selecting children in ways such as those patented by 23andMe is hugely ethically controversial… We believe the patent office made a serious mistake in allowing a patent that includes drop-down menus from which to choose a future child’s traits… At no stage during the examination of the patent application Read More >

Patently BIOtech  |  2 Comments  |  Email This Post
Tags: , ,

New Bill Calls for No WTO-Plus Benefits for Countries that Violate IP

flags with blue sky

A new Bill in the U.S. House of Representatives seeks to remove WTO-plus trade benefits the United States provides to countries that disrespect intellectual property rights.  On September 20, 2013, Representative Terry introduced the “Playing Fair on Trade and Innovation Act.”  The Bill would deem countries ineligible for the Generalized System of Preferences program (GSP) if that country “fails to provide adequate and effective protection for intellectual property rights” or “maintains local content requirements…”  GSP Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,